First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012
Am J Hematol
.
2019 Jan;94(1):165.
doi: 10.1002/ajh.25138.
Epub 2018 Jul 23.
Authors
Andrea Bacigalupo
1
,
Rosi Oneto
1
,
Hubert Schrezenmeier
2
,
Britta Hochsmann
2
,
Carlo Dufour
3
,
Seiji Kojima
4
,
Xiaofan Zhu
5
,
Xiaojuan Chen
5
,
Surapol Issaragrisil
6
,
Suporn Chuncharunee
6
,
Dae Chul Jeong
7
,
Sabrina Giammarco
1
,
Maria Teresa Van Lint
8
,
Yizhou Zheng
9
,
Carlos Vallejo
10
Affiliations
1
Istituto di Ematologia, Universita' Cattolica, Fondazione Universitaria Policlinico Gemelli, Roma, Italy.
2
Blutspende, Ulm University, Ulm, Germany.
3
Hematology Unity, IstitutoGiannina Gaslini, Genova, Italy.
4
Graduate School of Medicine, Department of Pediatric Hematology, Nagoya University, Nagoya, Japan.
5
Pediatric Department, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Blood Disease Hospital, Tianjin, China.
6
Mahidol University, Bangkok, Thailand.
7
Pediatric Department, The Catholic University of Korea, Seoul, Korea.
8
Divisione di E di Ematologia, IRCCS AOU San Martino, Genova, Italy.
9
Hematology Department, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Blood Disease Hosoital, Tianjin, China.
10
Hospital Universitario de Donostia, San Sebastian, Spain and PETHEMA- Spain.
PMID:
30561167
PMCID:
PMC6886037
DOI:
10.1002/ajh.25138
No abstract available
Publication types
Published Erratum